116 related articles for article (PubMed ID: 8856182)
1. Bradykinin excretion is increased in severely hyperglycemic streptozotocin-diabetic rats.
Tschöpe C; Gavriluk V; Reinecke A; Seidl U; Riester U; Hilgenfeldt U; Ritz E; Unger T
Immunopharmacology; 1996 Jun; 33(1-3):344-8. PubMed ID: 8856182
[TBL] [Abstract][Full Text] [Related]
2. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats.
Tschöpe C; Reinecke A; Seidl U; Yu M; Gavriluk V; Riester U; Gohlke P; Graf K; Bader M; Hilgenfeldt U; Pesquero JB; Ritz E; Unger T
Am J Physiol; 1999 Dec; 277(6):H2333-40. PubMed ID: 10600853
[TBL] [Abstract][Full Text] [Related]
3. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
4. Renal expression of two rat kallikrein genes under diabetic conditions.
Tschöpe C; Yu M; Reinecke A; Csikos T; Hilgenfeldt U; Pesquero JB; Ritz E; Unger T
J Hypertens; 1997 Dec; 15(12 Pt 2):1711-4. PubMed ID: 9488227
[TBL] [Abstract][Full Text] [Related]
5. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
6. Myocardial expression of rat bradykinin receptors and two tissue kallikrein genes in experimental diabetes.
Tschöpe C; Walther T; Yu M; Reinecke A; Koch M; Seligmann C; Heringer SB; Pesquero JB; Bader M; Schultheiss H; Unger T
Immunopharmacology; 1999 Oct; 44(1-2):35-42. PubMed ID: 10604522
[TBL] [Abstract][Full Text] [Related]
7. Urinary active kallikrein excretion and diabetic renal impairments in streptozotocin-treated rats.
Yasujima M; Yoshida K; Kanazawa M; Kohzuki M; Omata K; Watanabe H; Hiwatari M; Sato T; Abe K
Tohoku J Exp Med; 1993 Oct; 171(2):135-44. PubMed ID: 8128482
[TBL] [Abstract][Full Text] [Related]
8. Increased activity of the renal kallikrein-kinin system in autosomal dominant polycystic kidney disease in rats, but not in humans.
Braun C; Kleemann T; Birck R; Hilgenfeldt U; Riester U; Tschöpe C; van der Woude FJ; Rohmeiss P
Int Immunopharmacol; 2002 Dec; 2(13-14):1949-56. PubMed ID: 12489808
[TBL] [Abstract][Full Text] [Related]
9. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
[TBL] [Abstract][Full Text] [Related]
10. The development of insulitis and the kallikrein-kinin system.
Zucollo A; Dziubecki D; Villareal I; Rodriguez R; Catanzaro O
Int Immunopharmacol; 2002 Dec; 2(13-14):1941-7. PubMed ID: 12489807
[TBL] [Abstract][Full Text] [Related]
11. Kinin, a mediator of diabetes-induced glomerular hyperfiltration.
Jaffa AA; Rust PF; Mayfield RK
Diabetes; 1995 Feb; 44(2):156-60. PubMed ID: 7859934
[TBL] [Abstract][Full Text] [Related]
12. The kallikrein-kinin system.
Tang SC; Leung JCK; Lai KN
Contrib Nephrol; 2011; 170():145-155. PubMed ID: 21659767
[TBL] [Abstract][Full Text] [Related]
13. Effects of benidipine, a calcium antagonist, on urinary kallikrein excretion and renal impairment in experimental diabetes.
Yoshida K; Kohzuki M; Yasujima M; Kanazawa M; Abe K
J Hypertens; 1996 Feb; 14(2):215-22. PubMed ID: 8728299
[TBL] [Abstract][Full Text] [Related]
14. Effects of B1 and B2 kinin receptor antagonists in diabetic mice.
Zuccollo A; Navarro M; Catanzaro O
Can J Physiol Pharmacol; 1996 May; 74(5):586-9. PubMed ID: 8884024
[TBL] [Abstract][Full Text] [Related]
15. Decreased urinary kallikrein with hyperglycemia in patients with short-term insulin-dependent diabetes mellitus.
Pelikánová T; Pinsker P; Smrcková I; Stribrná L; Dryáková M
J Diabetes Complications; 1998; 12(5):264-72. PubMed ID: 9747643
[TBL] [Abstract][Full Text] [Related]
16. Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.
Hilgenfeldt U; Puschner T; Riester U; Finsterle J; Hilgenfeldt J; Ritz E
Am J Physiol; 1998 Jul; 275(1):F88-93. PubMed ID: 9689009
[TBL] [Abstract][Full Text] [Related]
17. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model.
Palm F; Ortsäter H; Hansell P; Liss P; Carlsson PO
Diabetes Metab Res Rev; 2004; 20(6):452-9. PubMed ID: 15386825
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the cardiovascular responses elicited by kinin B(1) and B(2) receptor agonists in the spinal cord of streptozotocin-diabetic rats.
Cloutier F; Couture R
Br J Pharmacol; 2000 May; 130(2):375-85. PubMed ID: 10807676
[TBL] [Abstract][Full Text] [Related]
19. Renal kallikrein and hemodynamic abnormalities of diabetic kidney.
Harvey JN; Jaffa AA; Margolius HS; Mayfield RK
Diabetes; 1990 Mar; 39(3):299-304. PubMed ID: 1689683
[TBL] [Abstract][Full Text] [Related]
20. The diabetic nephropathy and the development of hypertension in rats.
Zuccollo A; Navarro M; Catanzaro O
Int J Exp Diabetes Res; 2001; 2(3):195-9. PubMed ID: 12369707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
